[Adjunctive thyroid hormone therapy and comparison between responders and non-responders]

Area of Science:

• Endocrinology
• Psychiatry
• Pharmacology

Background:

• Adjunctive thyroid hormone therapy is explored for treatment-resistant depression.
• Conventional antidepressants are not maximally effective for all patients with depression.

Purpose of the Study:

• To investigate the efficacy of adjunctive thyroid hormone therapy in depressed patients.
• To identify predictors of treatment response to thyroid hormone supplementation.

Main Methods:

• Serum levels of thyroxine (T4), triiodothyronine (T3), and reverse triiodothyronine (rT3) were measured.
• Eight depressed patients received thyroid hormone supplementation alongside existing antidepressant medication.

Main Results:

• Four out of eight patients demonstrated significant clinical improvement.
• Responders had lower baseline T4 and rT3 levels compared to non-responders.
• Patients with rT3 < 200 pg/ml and T4 < 7 µg/dl showed a positive treatment response.

Conclusions:

• Lower baseline T4 and rT3 levels may predict treatment response to adjunctive thyroid hormone therapy in depression.
• Thyroid hormone supplementation can be a viable option for specific patient subgroups.